|
Heart burn
|
|
Q2: A lot of heart burn
|
6.1
|
7.9
|
6.3
|
6.2
|
4.9
|
6.3
|
8.6
|
7.9
|
|
GPD: Heart burn or reflux (D03/D84)
|
3.9
|
8.2
|
10.0
|
11.0
|
2.5
|
7.6
|
12.1
|
12.0
|
|
Cardiovascular diseases
|
|
Q1: Angina pectoris
|
0.3
|
1.5
|
9.6
|
21.4
|
0.2
|
0.7
|
4.4
|
15.5
|
|
GPD: Angina pectoris (K74)
|
0.1
|
2.2
|
13.9
|
26.4
|
0
|
0.8
|
6.8
|
21.1
|
|
Q1: Myocardial infarction
|
0.1
|
2.3
|
10.1
|
21.2
|
0.0
|
0.5
|
3.0
|
8.6
|
|
GPD: Myocardial infarction (K75or K76)
|
1.0
|
3.3
|
12.9
|
18.8
|
0.5
|
1.3
|
4.7
|
10.4
|
|
Q1: Cerebral insult
|
0.6
|
1.5
|
5.4
|
11.6
|
0.3
|
1.1
|
3.9
|
8.6
|
|
GPD: Cerebral insult (K90 + 91)
|
0.4
|
2.2
|
7.3
|
17.0
|
0.4
|
1.4
|
5.7
|
14.2
|
|
Q1: Arterial hypertension
|
1.2
|
14.7
|
38.1
|
44.1
|
2.1
|
12.7
|
36.9
|
49.8
|
|
GPD: Arterial hypertension (K86 or K87)
|
2.7
|
14.7
|
37.4
|
42.2
|
2.2
|
12.9
|
37.1
|
49.4
|
|
NorPD: Drugs arterial hyper-tension (C02-03, 07–09)
|
1.7
|
16.0
|
51.5
|
70.3
|
2.2
|
15.7
|
49.5
|
67.7
|
|
Inflammatory and musculoskeletal diseases
|
|
Q1: Spondylarthritis or
|
|
rheumatoid arthritis
|
1.5
|
4.1
|
5.3
|
6.0
|
1.9
|
4.7
|
7.2
|
8.8
|
|
GPD: Spondylarthritis or rheumatoid arthritis (L88)
|
1.5
|
3.4
|
4.5
|
5.6
|
1.5
|
4.7
|
7.9
|
8.7
|
|
Q1: Arthrosis
|
0.8
|
6.1
|
17.2
|
23.3
|
1.0
|
12.8
|
34.2
|
45.5
|
|
GPD: Arthrosis hip or knee (L 89 + 90 + 91)
|
1.7
|
7.5
|
21.5
|
29.8
|
1.7
|
10.2
|
33.6
|
43.4
|
|
Q1: Osteoporosis
|
0.1
|
0.3
|
1.2
|
3.1
|
0.3
|
1.9
|
11.1
|
20.6
|
|
GPD: Osteoporosis L95
|
0.2
|
0.6
|
1.5
|
2.9
|
0.2
|
1.4
|
10.8
|
22.7
|
|
Neurological diseases
|
|
Q1: Headache
|
37.0
|
34.3
|
18.7
|
10.7
|
56.9
|
47.7
|
26.8
|
16.6
|
|
GPD: Headache (N01)
|
10.8
|
9.9
|
7.9
|
6.1
|
18.6
|
16.5
|
12.6
|
11.0
|
|
Q1: Migraine
|
3.1
|
4.5
|
2.7
|
3.4
|
10.4
|
11.2
|
5.1
|
5.0
|
|
GPD: Migraine (N89)
|
3.8
|
4.4
|
2.6
|
1.5
|
9.5
|
11.6
|
7.1
|
2.4
|
|
NorPD: Use of migraine drugs (N02)
|
1.0
|
1.0
|
0.5
|
0.2
|
3.5
|
4.9
|
2.0
|
0.3
|
|
Q1: Epilepsy
|
1.5
|
1.2
|
1.2
|
1.9
|
1.3
|
1.4
|
0.7
|
1.4
|
|
GPD: Epilepsy (N88)
|
1.8
|
1.7
|
1.8
|
1.5
|
1.5
|
1.7
|
1.5
|
1.2
|
|
Mental diseases and insomnia
|
|
Q2: HADS anxiety score > 8#
|
11.9
|
11.7
|
7.2
|
8.2
|
18.4
|
17.4
|
15.6
|
13.2
|
|
GPD: Anxiety or feeling of anxiety (P 01 + 74 +79)
|
6.7
|
8.5
|
8.5
|
8.6
|
9.7
|
14.1
|
14.0
|
15.4
|
|
Q2: HADS depression score > 8#
|
6.4
|
9.4
|
11.7
|
18.8
|
6.2
|
8.3
|
9.8
|
16.3
|
|
GPD: Depression or feeling of depression (P 03 + 76)
|
11.0
|
18.1
|
16.0
|
11.1
|
19.6
|
31.3
|
28.0
|
21.7
|
|
Q2: Insomnia many evenings or mornings a week
|
11.6
|
13.8
|
16.2
|
15.4
|
13.1
|
21.3
|
25.8
|
25.3
|
|
GPD: Sleeping disorder (P06)
|
6.3
|
8.6
|
18.8
|
24.0
|
6.3
|
13.3
|
21.7
|
32.4
|
|
Q1: COPD or chronic bronch
|
1.0
|
2.0
|
5.6
|
5.4
|
1.5
|
2.7
|
4.6
|
4.2
|
|
GPD: COPD or chronic bronchitis (R95)
|
0.1
|
1.9
|
7.9
|
13.2
|
0.2
|
1.8
|
7.2
|
7.0
|
|
Q1: Asthma
|
10.5
|
9.3
|
9.4
|
7.2
|
12.4
|
9.4
|
10.4
|
8.6
|
|
GPD: Asthma (R96)
|
10.6
|
7.0
|
9.2
|
10.0
|
10.4
|
9.7
|
11.9
|
9.9
|
|
Q1: Use of asthma or copd drugs in the last 5 years
|
8.1
|
7.5
|
11.3
|
9.6
|
10.4
|
9.6
|
12.5
|
9.7
|
|
GP prescription asthma drugs in the last 5 year (R03)
|
7.4
|
8.7
|
15.1
|
17.4
|
9.8
|
11.4
|
17.3
|
12.6
|
|
NorPD: Use of asthma drugs in 2008 (R03)
|
4.6
|
5.6
|
11.6
|
14.2
|
5.7
|
7.7
|
13.0
|
9.1
|
|
Skin diseases
|
|
Q1: Psoriasis
|
4.1
|
6.8
|
7.0
|
3.8
|
3.3
|
6.2
|
6.6
|
4.1
|
|
GPD: Psoriasis (S91)
|
2.0
|
4.6
|
5.5
|
4.6
|
2.7
|
4.5
|
5.8
|
2.8
|
|
Endocrine disorders
|
|
Q1: Hyperthyreosis
|
0.3
|
0.7
|
1.3
|
2.5
|
1.4
|
2.6
|
3.4
|
3.2
|
|
GPD: Hyperthyreosis (T85)
|
0.2
|
0.5
|
0.7
|
0.7
|
0.6
|
1.9
|
2.0
|
2.0
|
|
Q1: Hypothyreosis
|
0.6
|
2.1
|
2.9
|
5.3
|
4.1
|
8.0
|
12.3
|
12.1
|
|
GPD: Hypothyreosis (T86)
|
1.4
|
1.9
|
4.2
|
6.7
|
3.2
|
7.8
|
12.7
|
13.8
|
|
GP prescription thyroid hormone (H03AA01)
|
0.5
|
1.5
|
3.3
|
5.1
|
2.2
|
7.0
|
12.1
|
12.5
|
|
NorPD: Use of thyroid hormone (H03AA01)
|
0.5
|
2.0
|
3.7
|
5.9
|
2.6
|
7.9
|
14.2
|
13.4
|
|
Q1: Diabetes mellitus
|
0.8
|
3.4
|
9.2
|
9.2
|
0.8
|
2.4
|
6.9
|
9.7
|
|
GPD: Diabetes mellitus (T89 + 90)
|
1.2
|
4.8
|
13.7
|
16.3
|
1.4
|
3.6
|
10.4
|
13.0
|
|
GP prescription antidiabetic drug (A10A or A10B)
|
0.8
|
4.0
|
10.9
|
10.9
|
1.2
|
2.8
|
7.9
|
8.8
|
|
NorPD: Antidiabetic drug (A10A or A10B)
|
1.1
|
4.1
|
11.1
|
11.7
|
1.5
|
2.6
|
8.4
|
9.2
|
|
Urinary tract
|
|
Q2: Urinary incontinence
|
4.7
|
7.6
|
10.4
|
13.1
|
22.2
|
27.5
|
27.4
|
32.8
|
|
GPD: Urinary incontinence (U04)
|
1.0
|
0.5
|
3.0
|
8.7
|
2.2
|
6.8
|
10.5
|
22.0
|
